Brainsway Ltd - ADR
BWAY - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$224.93M
Close$
$3.57
68.1% downside
Current Fair Value
68.1% downsideOvervalued by 68.1% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $224.93 Million |
|---|---|
| Enterprise Value | $179.89 Million |
| Earnings per Share | $0.4 |
| Beta | 0.15 |
| Outstanding Shares | 20,064,705 |
Return
| Return on Equity | 12.76% |
|---|---|
| Return on Assets | 8.28% |
| Return on Invested Capital | 5.09% |
Valuation & Multiples
| P/E Ratio | 49.12 |
|---|---|
| PEG | 149.16 |
| Price to Sales | 3.74 |
| Price to Book Ratio | 2.8 |
| Enterprise Value to Revenue | 2.77 |
| Enterprise Value to EBIT | 35.59 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.1 |
| Debt to Equity | 0.22 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 12, 2026
EPS Estimate
$0.10
Consensus analyst estimateRevenue Estimate
$16.54 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
$0.12
Consensus analyst estimateRevenue Estimate
$17.80 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.43%▼ 56.43% |
|---|---|
| Total Invested | $1.14M▼ 99.36% |
| Investors Holding | 5▼ 53.00% |
About Brainsway Ltd.
129 employees
CEO: Christopher von Jako
Brainsway Ltd. is a commercial stage medical device company, which focuses on the development and sale of non-invasive neuromodulation products using the proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the tr...